{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:14:59Z","timestamp":1793229299944,"version":"4.5.0"},"reference-count":25,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,7,23]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>New-onset refractory status epilepticus (NORSE) presents a significant challenge, particularly in the absence of a clear aetiology and resistance to conventional treatments. Managing NORSE during pregnancy is even more complex due to the lack of established guidelines and concerns over the teratogenicity of available antiepileptic drugs (AEDs).<\/jats:p>\n               <jats:p>A previously healthy pregnant woman with no history of seizures developed refractory NORSE, resistant to multiple AEDs and anaesthetic infusions. A provisional diagnosis of autoimmune encephalitis was considered and treated with pulse steroids and IV immunoglobulins, but her seizures persisted. Given the refractoriness of her condition, electroconvulsive therapy (ECT) was initiated, leading to gradual clinical improvement. This allowed for the tapering off of anaesthetic medications and ventilator support.<\/jats:p>\n               <jats:p>The patient was eventually discharged after 42 days of hospital stay on multiple AEDs, without any residual deficits. This case underscores the potential role of ECT as a viable therapeutic option in such complex scenarios.<\/jats:p>","DOI":"10.1136\/bcr-2025-266413","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T07:35:14Z","timestamp":1754552114000},"page":"e266413","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Rescue use of electroconvulsive therapy in new-onset refractory status epilepticus during pregnancy"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6971-1236","authenticated-orcid":false,"given":"Venkat Raman","family":"Kola","sequence":"first","affiliation":[{"name":"Critical Care Medicine, Yashoda Group of Hospitals, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0390-9954","authenticated-orcid":false,"given":"Sai Sreeharshita","family":"Malla","sequence":"additional","affiliation":[{"name":"Research and Projects, Indian Institute of Public Health Hyderabad, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbaiah Chowdhary","family":"GV","sequence":"additional","affiliation":[{"name":"Neurology, Yashoda Group of Hospitals, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Bandla","sequence":"additional","affiliation":[{"name":"Critical Care Medicine, Yashoda Group of Hospitals, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"2025082709015008000_18.8.e266413.1","doi-asserted-by":"crossref","unstructured":"Carrasco C , Schwalk A , Hwang B , et al . Super-refractory status epilepticus in a 29-year-old pregnant female. SAGE Open Med Case Rep 2021;9. doi:10.1177\/2050313X211000455","DOI":"10.1177\/2050313X211000455"},{"key":"2025082709015008000_18.8.e266413.2","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2020-002534"},{"key":"2025082709015008000_18.8.e266413.3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.seizure.2020.05.022","article-title":"New-onset epilepsy in women with first time seizures during pregnancy","volume":"80","author":"Ma","year":"2020","journal-title":"Seizure"},{"key":"2025082709015008000_18.8.e266413.4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/epi4.12113","article-title":"Jamestown Canyon encephalitis with NORSE and electrographic response to ribavirin: a case report","volume":"3","author":"Savard","year":"2018","journal-title":"Epilepsia Open"},{"key":"2025082709015008000_18.8.e266413.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-013-0252-7"},{"key":"2025082709015008000_18.8.e266413.6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2169\/internalmedicine.54.2047","article-title":"Refractory Status Epilepticus Caused by Anti-NMDA Receptor Encephalitis that Markedly Improved Following Combination Therapy with Rituximab and Cyclophosphamide","volume":"54","author":"Kadoya","year":"2015","journal-title":"Intern Med"},{"key":"2025082709015008000_18.8.e266413.7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yebeh.2017.07.002","article-title":"Status epilepticus in pregnancy: Etiology, management, and clinical outcomes","volume":"76","author":"Rajiv","year":"2017","journal-title":"Epilepsy & Behavior"},{"key":"2025082709015008000_18.8.e266413.8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.041947"},{"key":"2025082709015008000_18.8.e266413.9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.seizure.2017.02.015","article-title":"Challenges in the treatment of convulsive status epilepticus","volume":"47","author":"Zaccara","year":"2017","journal-title":"Seizure"},{"key":"2025082709015008000_18.8.e266413.10","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000396","article-title":"Cryptogenic NORSE: Its distinctive clinical features and response to immunotherapy","volume":"4","author":"Iizuka","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025082709015008000_18.8.e266413.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.12.015"},{"key":"2025082709015008000_18.8.e266413.12","first-page":"4495","article-title":"Retrospective review of 6 patients with new-onset refractory status epilepticus (NORSE) syndrome: Early intervention with intravenous cyclophosphamide may improve outcome","volume":"92","author":"Kaneko","year":"2019","journal-title":"Neurology (ECronicon)"},{"key":"2025082709015008000_18.8.e266413.13","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.14336\/AD.2021.0302","article-title":"Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management","volume":"12","author":"Kirmani","year":"2021","journal-title":"Aging Dis"},{"key":"2025082709015008000_18.8.e266413.14","first-page":"135","article-title":"Febrile Infection-Related Epilepsy Syndrome Treated Successfully With Anakinra in a 21-Year-Old Woman","volume":"118","author":"Furstenberg-Knauff","year":"2019","journal-title":"WMJ"},{"key":"2025082709015008000_18.8.e266413.15","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1212\/WNL.0000000000208208","article-title":"Treatment of Anti-GAD65 Autoimmune Encephalitis Presenting as NORSE with Intrathecal Dexamethasone (P1-14.005)","volume":"102","author":"Salazar","year":"2024","journal-title":"Neurology"},{"key":"2025082709015008000_18.8.e266413.16","doi-asserted-by":"crossref","unstructured":"Stredny CM , Case S , Sansevere AJ , et al . Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES). Child Neurol Open 2020;7. doi:10.1177\/2329048X20979253","DOI":"10.1177\/2329048X20979253"},{"key":"2025082709015008000_18.8.e266413.17","first-page":"699","article-title":"Anakinra in the treatment of new-onset refractory status epilepticus: Our experience from a clinical case","volume":"28","author":"Palacios Mendoza","year":"2021","journal-title":"Eur J Neurol"},{"key":"2025082709015008000_18.8.e266413.18","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1212\/WNL.94.15_supplement.4495","article-title":"Tocilizumab in new onset refractory status epilepticus (NORSE)-A report of the first case from India","volume":"94","author":"Alluru","year":"2020","journal-title":"Neurology (ECronicon)"},{"key":"2025082709015008000_18.8.e266413.19","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25374"},{"key":"2025082709015008000_18.8.e266413.20","doi-asserted-by":"crossref","first-page":"100431","DOI":"10.1016\/j.ebr.2021.100431","article-title":"Resolution of cryptogenic new onset refractory status epilepticus with tocilizumab","volume":"15","author":"Donnelly","year":"2021","journal-title":"Epilepsy & Behavior Reports"},{"key":"2025082709015008000_18.8.e266413.21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.12809\/hkmj154501","article-title":"Electroconvulsive therapy for new-onset super-refractory status epilepticus","volume":"24","author":"Chan","year":"2018","journal-title":"Hong Kong Med J"},{"key":"2025082709015008000_18.8.e266413.22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.14581\/jer.19008","article-title":"Successful Treatment of Super-Refractory Status Epilepticus with High-Intensity Electroconvulsive Therapy - A Case Report and Review of the Current Literature","volume":"9","author":"Schneegans","year":"2019","journal-title":"J Epilepsy Res"},{"key":"2025082709015008000_18.8.e266413.23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/0972-2327.157250","article-title":"Electroconvulsive therapy for refractory status epilepticus in a child: A case report","volume":"18","author":"Incecik","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"key":"2025082709015008000_18.8.e266413.24","doi-asserted-by":"publisher","DOI":"10.1097\/YCT.0000000000000450"},{"key":"2025082709015008000_18.8.e266413.25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.psym.2017.10.004","article-title":"Targeted Electroconvulsive Therapy for Super Refractory Status Epilepticus: A Case Report and Literature Review","volume":"59","author":"Pinchotti","year":"2018","journal-title":"Psychosomatics"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-266413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:01:59Z","timestamp":1756310519000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-266413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,6]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bcr-2025-266413"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-266413","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}